Voyager Therapeutics Names Robin Swartz President

PUBT · 1d ago
Voyager Therapeutics Names Robin Swartz President
  • Voyager Therapeutics appointed Robin Swartz president, effective October 20, 2026. She previously served as chief business officer and chief operating officer.
  • Swartz is expected to succeed Alfred W. Sandrock, Jr. as CEO in the first quarter of 2027.
  • The transition follows initial acute safety data from the VY1706 trial in adults with early Alzheimer's disease, expected that quarter pending enrollment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Voyager Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610210801PRIMZONEFULLFEED9849985) on October 21, 2026, and is solely responsible for the information contained therein.